SCHEMBL1990281

SCHEMBL1990281

COc1ccc(S(=O)(=O)c2ccc(-c3cc(F)ccc3O)cc2F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.43
GAA P10253 1/20 0.43
STAT3 P40763 3/20 0.43
CNR1 P21554 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MMP2 P08253 4/20 0.40
MMP9 P14780 4/20 0.40
MMP12 P39900 4/20 0.40
MMP3 P08254 3/20 0.40
MMP8 P22894 3/20 0.40
MMP13 P45452 3/20 0.40
MMP14 P50281 3/20 0.40
MMP16 P51512 3/20 0.40
MMP1 P03956 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989399 0.84 POLB (0.47) GAALMNAMMP2MMP9MMP12
SCHEMBL1989421 0.81 NPC1 (0.44) MEN1KMT2ANPC1RAB9APTGS1
SCHEMBL1988525 0.80 GRM5 (0.46) GAALMNAMEN1KMT2AUSP2
SCHEMBL1995866 0.80 ABCB11 (0.46) CNR1MMP2MMP9MMP12MMP3
SCHEMBL2356023 0.79 MMP2 (0.39) STAT3CNR1MMP2MMP9MMP12
SCHEMBL14432857 0.79 MMP2 (0.39) STAT3CNR1MMP2MMP9MMP12
SCHEMBL1993521 0.79 POLB (0.46) GAACNR1MEN1KMT2APTGS1
SCHEMBL1995847 0.78 SYK (0.51) STAT3CNR1SMN1; SMN2MMP2MMP9
SCHEMBL1996020 0.77 HTR2A (0.43) LMNAMEN1KMT2AUSP2
SCHEMBL2356017 0.77 CNR1 (0.40) STAT3CNR1MMP2MMP9MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415394-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (GB) 2013-04-09 US disclosed
US-8349897-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2013-01-08 US disclosed
US-20120178814-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease LUKER TIMOTHY JON (GB) 2012-07-12 US disclosed
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2011-06-23 US disclosed
EP-1937633-B1 BIPHENYLOXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASE ASTRAZENECA AB (SE) 2010-08-04 EP disclosed
US-20090036535-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178814-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PKM 1408/4885GAA 54/4885STAT3 3574/4885
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PKM 1408/4885GAA 54/4885STAT3 3574/4885
US-20090036535-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PKM 1408/4885GAA 54/4885STAT3 3574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.